U.S. Auto Stock News

LendingClub (LC) just delivered a stronger quarter, with revenue and net income up solidly from last year, and that combination of earnings momentum and heavy loan demand is starting to reshape how investors view the stock. See our latest analysis for LendingClub. The upbeat quarter lands on top of an already strong run, with a roughly 21.8% year to date share price return and a powerful three year total shareholder return of about 126.6% suggesting momentum is firmly building. If...

If you are wondering whether CME Group is still worth buying after its long run, or if the market has already priced in the upside, you are not alone. That is exactly what we are going to unpack here. The stock has slipped around 1.6% over the last week and 1.5% over the past month, but it is still up 15.6% year to date and 17.8% over the last year, with multi year returns above 78% over three years and 82.2% over five years. Recent market attention has centered on CME as a key beneficiary...

The latest joint venture acquisition of the 195,000 square foot Springs Plaza center in Bonita Springs puts Phillips Edison (PECO) back in focus and highlights how it is leaning into high growth, necessity retail markets. See our latest analysis for Phillips Edison. That Springs Plaza deal slots neatly into a year where momentum has been steady rather than spectacular, with a modest positive multi month share price return and a solid three year total shareholder return of 25 percent...

Evolv Technologies Holdings (EVLV) is back in the spotlight after announcing its Evolv Express systems are being installed at the 14,000 seat Pechanga Arena San Diego, further extending its footprint across major California venues. See our latest analysis for Evolv Technologies Holdings. That expanding customer list seems to be feeding into sentiment, with the share price at $7.21 and a strong year to date share price return alongside a robust one year total shareholder return, suggesting...

Amgen (AMGN) just checked two big boxes at once, tightening its partnership with Washington on drug pricing while winning FDA approval for UPLIZNA in generalized myasthenia gravis, and the stock is reacting accordingly. See our latest analysis for Amgen. That backdrop of tariff relief and drug price cooperation, combined with the fresh UPLIZNA approval, comes on top of a strong run, with Amgen’s share price up 26.27% year to date and a 5 year total shareholder return of 71.89%, which suggests...

Celanese (CE) has had a choppy year in the market, with the stock sliding sharply year to date even as revenue edges higher and net income rebounds from a deep loss. Investors are now reassessing what that disconnect really means. See our latest analysis for Celanese. At around $42.29 per share, Celanese’s 11.49% 1 month share price return looks like a short term bounce within a much tougher backdrop. The 5 year total shareholder return is still deeply negative and momentum appears more...

Triumph Financial (TFIN) is back in the spotlight after BlueGrace Logistics joined the Triumph Network, a move that tightens Triumph’s grip on fintech powered freight payments and back office automation. See our latest analysis for Triumph Financial. The BlueGrace deal comes as Triumph’s 30 day share price return of 15.91% and 90 day share price return of 12.26% clash with a much weaker year to date share price return of minus 30.07%. However, the three year total shareholder return of 25.55%...

Earlier in December 2025, Azenta, Inc. announced a US$250,000,000 share repurchase program running through 2028 and, at its Investor Day, outlined plans to deploy its balance sheet toward disciplined M&A focused on high-margin, recurring-revenue life sciences assets. Management highlighted a funnel of about 60 potential acquisition targets and emphasized strict financial filters, including margin accretion, double-digit ROIC within three to five years, and a bias toward tuck-in deals in...

Earlier in December 2025, the U.S. FDA issued a warning letter to Target after recalled ByHeart Whole Nutrition Infant Formula linked to an infant botulism outbreak remained on sale in multiple Target stores across 20 states despite recall notices. The letter highlights not just product safety concerns but also serious weaknesses in Target’s recall execution and regulatory communications, raising questions about its internal controls for high-risk consumer goods. We’ll now examine how this...

Kimberly-Clark (KMB) has been sliding lately, with the stock down about 4% over the past month and almost 19% in the past 3 months, even as earnings and revenue continue to grow. See our latest analysis for Kimberly-Clark. That slide comes after a tougher stretch for Kimberly-Clark, with the share price returning about negative 23 percent year to date and total shareholder return down roughly 20 percent over the past year. This suggests momentum has clearly faded despite improving...

In recent weeks, XPEL outlined an ambitious US$75–US$150 million capital expenditure plan over the next two years while insiders increased their shareholdings, and an analyst cited potential margin gains as reinforcing the company’s operational strength. This combination of growth investment, insider buying, and confidence in profitability sends a strong signal about how management views XPEL’s long‑term positioning in the paint protection and automotive personalization market. We’ll now...

In recent weeks, Li Auto has faced its first quarterly loss after 11 profitable quarters, hit by a recall of its MEGA model, weaker sales and margins, and analyst downgrades, even as it gained approval to test Level 3 autonomous driving in Beijing. At the same time, Li Auto has accelerated its overseas push into Egypt, Kazakhstan, and Azerbaijan and opened new global AI R&D hubs, signaling a bid to offset domestic pressure with international growth and smarter driving technology. We’ll now...

Earlier this month, EMASS announced a collaboration with Semtech to integrate Semtech’s LoRa transceivers into EMASS’s ECS-DoT low-power edge AI SoCs, enabling long-range, battery-efficient intelligence for industrial, IoT, and security applications and showcasing multiple real-world reference designs at CES 2026 venues including Semtech’s and the LoRa Alliance’s locations. This partnership reinforces Semtech’s push to pair its LoRaWAN connectivity with edge AI processing, aiming to reduce...

Earlier this month, Stewart Information Services completed a follow-on equity offering of 1,900,000 common shares at US$68, raising about US$129.2 million, while also filing an omnibus shelf registration covering common and preferred stock, warrants, units, debt securities and purchase contracts. This combination of fresh equity capital and expanded financing flexibility could meaningfully influence investor views on dilution, balance sheet strength and future funding options. Next, we’ll...

Live Nation Entertainment (LYV) is deepening its footprint in Asia by taking over operations at Bangkok's Impact Arena, pairing venue upgrades with a push for more shows, brand partnerships, and higher quality fan experiences. See our latest analysis for Live Nation Entertainment. That Asia push comes as Live Nation’s share price sits at $141.1, with a solid 1 month share price return of just over 8 percent but a weaker 3 month stretch, while its roughly 100 percent 3 year total shareholder...

In December 2025, FedEx reported fiscal second-quarter 2026 results showing sales of US$23,469 million and net income of US$956 million, raised its full-year 2026 revenue growth guidance to 5%–6%, completed a US$3,775.61 million share buyback program, and filed a US$592.64 million ESOP-related shelf registration. At the same time, FedEx flagged roughly US$175 million in costs from the temporary grounding of its MD-11 fleet and confirmed plans to spin off FedEx Freight by June 1, 2026,...

Celcuity (CELC) just gave investors fresh Phase 3 data on its lead drug gedatolisib at the San Antonio Breast Cancer Symposium, highlighting longer progression free survival and manageable side effects across important advanced breast cancer subgroups. See our latest analysis for Celcuity. The latest VIKTORIA-1 update comes after a powerful run, with Celcuity’s 90 day share price return of 92.72 percent and a standout year to date share price return of 670.45 percent. Its one year total...

Bitdeer Technologies Group (BTDR) is back in the spotlight after disappointing third quarter 2025 results and delays in its SEAL04 ASIC chip sparked multiple securities class action lawsuits and fresh questions about the miner's growth story. See our latest analysis for Bitdeer Technologies Group. The recent wave of lawsuits and SEAL04 delays comes after a sharp reset in sentiment, with the 90 day share price return sitting at around negative 38 percent and the one year total shareholder...

IonQ recently announced an expanded agreement with Switzerland’s QuantumBasel, lifting the partnership’s value to over US$60 million, granting QuantumBasel ownership of its existing Forte Enterprise system and a future Tempo system, and extending IonQ’s on-site presence on the uptownBasel campus through 2029. This deal cements QuantumBasel as IonQ’s official European Innovation Center and, alongside fresh collaborations in advanced therapies, anchors IonQ’s push to turn high-fidelity...

Valaris (VAL) just locked in a multi year contract with Shell for its VALARIS DS-8 drillship offshore Brazil. This long dated deal gives investors more visibility into future revenue. See our latest analysis for Valaris. That backdrop helps explain why, even after a recent soft patch with a 7 day share price return of minus 8.54 percent and a 30 day share price return of minus 8.59 percent, Valaris still sits at a year to date share price return of 10.07 percent and a 1 year total shareholder...

Earlier in December 2025, StandardAero, Inc. (NYSE:SARO) announced that its board had authorized a share repurchase program of up to US$450,000,000 of common stock. This sizable buyback authorization, highlighted alongside management’s appearance at Bernstein’s Industrials Forum in New York, underscores how the company is communicating confidence in its capital allocation priorities. With StandardAero’s new US$450,000,000 repurchase plan in focus, we’ll now examine how this decision shapes...

Recently, BTIG began covering Workday, Inc. and the company closed its US$1.10 billion acquisition of AI-driven learning software firm Sana, while guiding for 14.4% subscription revenue growth for the fiscal year ending January 2026, including contributions from Sana and a US Defense Intelligence Agency contract. Taken together, the new AI-focused acquisition and upgraded revenue outlook underscore Workday’s effort to deepen its AI capabilities and expand its enterprise footprint. Next,...

Recent commentary on SPX Technologies highlighted that over the past five years the company has delivered a compounded annual revenue growth rate of 10.1%, while lifting its operating margin by 8.5 percentage points to 15.8% and growing earnings per share at a 17.4% compounded rate. This combination of consistent top-line expansion, improving profitability, and faster earnings growth per share points to effective execution that is likely drawing fresh investor attention to SPX Technologies’...

Earlier in December, major shareholder Hanwha Aerospace Co. Ltd increased its stake in NextDecade by buying roughly 1.65 million shares in open-market transactions worth about US$9.4 million, lifting its direct ownership to around 9.36%. The buying spree underscores Hanwha’s effort to build an integrated LNG value chain around NextDecade’s Rio Grande LNG project, which already has long-term contracts covering most of its expected output. With recent insider buying by Hanwha as a focal point,...